SPY423.11+2.25 0.53%
DIA339.45+0.67 0.20%
IXIC14,253.27+111.79 0.79%

Cellectar Biosciences Q1 EPS $(0.13) Up From $(0.42) YoY

Cellectar Biosciences (NASDAQ:CLRB) reported quarterly losses of $(0.13) per share. This is a 69.05 percent increase over losses of $(0.42) per share from the same period last year.

05/10/2021 08:31
Cellectar Biosciences (NASDAQ:CLRB) reported quarterly losses of $(0.13) per share. This is a 69.05 percent increase over losses of $(0.42) per share from the same period last year.